Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Non-Current Liabilities (2023 - 2025)

Zhengye Biotechnology Holding has reported Total Non-Current Liabilities over the past 3 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 95.82% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 95.82% year-over-year, with the annual reading at $1.3 million for FY2025, 101.82% up from the prior year.
  • Total Non-Current Liabilities was $1.3 million for Q4 2025 at Zhengye Biotechnology Holding, up from $656000.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.4 million in Q4 2023 and troughed at $656000.0 in Q2 2025.
  • The 3-year median for Total Non-Current Liabilities is $988393.9 (2024), against an average of $1.0 million.
  • Year-over-year, Total Non-Current Liabilities plummeted 53.66% in 2024 and then surged 95.82% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $1.4 million in 2023, then plummeted by 53.66% to $668235.5 in 2024, then surged by 95.82% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Total Non-Current Liabilities are $1.3 million (Q4 2025), $656000.0 (Q2 2025), and $668235.5 (Q4 2024).